Arterial hypertension and endothelial dysfunction in chronic kidney diseases
https://doi.org/10.18705/1607-419X-2006-12-4-352-357
Abstract
About the Authors
I. Y. PaninaRussian Federation
N. N. Petrichshtev
Russian Federation
A. V. Smirnov
Russian Federation
A. Sh. Rumyantsev
Russian Federation
O. A. Degtereva
Russian Federation
References
1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification //Am J Kidney Dis. 2002;39 (2 suppl 1):S1-S266
2. Sarnak M.J., Levey A.S. Cardiovascular disease and chronic renal disease: a new paradigm // Am J Kidney Dis. 2000 Apr: 35 (4 Suppl 1):S117-31
3. Mailloux L.U. Hypertension in chronic renal failure and ESRD: prevalence, pathophysiology, and outcomes.// Semin Nephrol- 2001.-vol. 21, N 2,- P146-156
4. Петрищев H.H. Патогенетическое значение дисфункции эндотелия // Омский научный вестник 2005, Вып 30, Приложение №1, С. 20-22
5. Amann К., Gross M-L., Ritz Е. Pathophysiology Underlying accelerated atherogenesis in renal disease: Closing in on the Target //J Am Soc Nephrol 2004; 15:1664-1666;
6. Смирнов A.B., Добронравов В.A., Каюков И.Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии // Нефрология 2005; 9(3): С. 7-12
7. Musial К., Zwolinska D., Polak-Jonkisz D., Berny U., Szprynger К., Szczepanska M. Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure. // Pediatr Nephrol. 2005-vol. 20, N 1-P52-55
8. Annuk M., Zilmer M., Fellstrom B. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: Impact on cardiovascular disease // Kidney Int. - 2003. -vol. 63, Suppl. 84. - P. 50 - 54
9. Ochodnicky P., Vettoretti S., Henning R.N. et al. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response/'/J Nephrol. - 2006; 19: 246-258
10. Levey A.S., Bosch J.P., Lewis J.B. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction indication. Modification of Diet in Renal Disease Study Group//Ann. Intern. Med. - 1999. - Vol. 130, N6.-P.471.
11. Devereux R.B., Reicheck N. Echocardiographic determination of left ventricular mass in men//Circulation.-1977.-Vol.55.-P.613-618
12. Dubious D., Dubious F. A formula to estimate the approximate surface area if height and weight are known// Arch.Intern.Med.-1916.-Vol.l7.-P.863-871
13. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging // Circulation.-1986.- vol. 6,- P. 1399-1406.
14. ESH-ESC Guidelines Committee. ESH-ESC guidelines for the management of arterial hypertension. // J Hypertens 2003; 21:1011-1053
15. Celermajer D.S., Sorensen K.E., Gooch V.M. et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis //'Lancet 1992 340 1111-1115
16. Петрищев H.H., Меншутина M.A., Власов Т.Д. и др. Патент на полезную модель №4720. Приоритет полезной модели от 12.04.2005
17. Yao Q., Lindholm В., Stenvinkel P. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients // Hemodialysis International. -2004.-Vol. 8, №2.-P. 118-123
18. Ребров А.П., Зелепукина Н.Ю. Дисфункция эндотелия у больных хроническим гломерулонефритом в различных стадиях почечной недостаточности // Нефрология и диализ. -2001.-Т. 3, № 4. - С. 39-46
19. Al-Nimri M.A., Komers R., Oyama T.T., Subramanya A.R. et al. Endothelial-derived vasoactive mediators in polycystic kidney disease // Kidney Int 2003; 63(5): 1776-1782
20. Hausberg M., Kisters Κ., Kosch M. et al. Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients// Kidney Int. 1999; 55: 1104-1110.
21. The SOLUD investigators. Effect of enalapril on survival inpatients with reduced left ventricular fractions and congestive heart failure // N England J Med. 1991.-Vol. 325. P. 293-302
22. Laursen J.B., Rajagopalan S., Galis H. et al. Role of superoxide in angiotenzin II-induced but not cathecholamine induced hypertension // Circulation 1997. Vol. 95 P. 588-593
23. Rohde L.E., Lee R.T., Rivero J. et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis // Arterioscler Tromb Vase Biol 1998; 18: 1765-1770
24. Papagianni A., Kalovoulos M., Kirmizis D. et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic hemodialysis patients // Nephrol Dial Transplant 2003; 18: P. 113-119
Review
For citations:
Panina I.Y., Petrichshtev N.N., Smirnov A.V., Rumyantsev A.Sh., Degtereva O.A. Arterial hypertension and endothelial dysfunction in chronic kidney diseases. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2006;12(4):352-357. (In Russ.) https://doi.org/10.18705/1607-419X-2006-12-4-352-357